Avalo Therapeutics
AVTX
AVTX
31 hedge funds and large institutions have $135M invested in Avalo Therapeutics in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% more funds holding
Funds holding: 20 → 31 (+11)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.5M | |
| 2 | +$1.97M | |
| 3 | +$1.03M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$793K |
| 5 |
Millennium Management
New York
|
+$777K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$203K | |
| 3 | -$118K | |
| 4 |
PC
PA Capital
Richmond,
Virginia
|
-$54K |
| 5 |
BlackRock
New York
|
-$34K |